Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 18593912)

1.

Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance.

Shachaf CM, Gentles AJ, Elchuri S, Sahoo D, Soen Y, Sharpe O, Perez OD, Chang M, Mitchel D, Robinson WH, Dill D, Nolan GP, Plevritis SK, Felsher DW.

Cancer Res. 2008 Jul 1;68(13):5132-42. doi: 10.1158/0008-5472.CAN-07-6192.

2.

Error occurred: cannot get document summary

PMID:
25835400

3.

Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.

Aravalli RN, Talbot NC, Steer CJ.

World J Gastroenterol. 2015 Feb 21;21(7):2011-29. doi: 10.3748/wjg.v21.i7.2011.

4.

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.

Hoellein A, Fallahi M, Schoeffmann S, Steidle S, Schaub FX, Rudelius M, Laitinen I, Nilsson L, Goga A, Peschel C, Nilsson JA, Cleveland JL, Keller U.

Blood. 2014 Sep 25;124(13):2081-90. doi: 10.1182/blood-2014-06-584524. Epub 2014 Aug 20.

PMID:
25143484
5.

MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state.

Li Y, Choi PS, Casey SC, Dill DL, Felsher DW.

Cancer Cell. 2014 Aug 11;26(2):262-72. doi: 10.1016/j.ccr.2014.06.014.

PMID:
25117713
6.

Analysis of gene expression for studying tumor progression: the case of glucocorticoid administration.

Huerta M, Fernández-Márquez J, Cabello JL, Medrano A, Querol E, Cedano J.

Gene. 2014 Oct 1;549(1):33-40. doi: 10.1016/j.gene.2014.07.027. Epub 2014 Jul 11.

PMID:
25017053
7.

Alteration of the lipid profile in lymphomas induced by MYC overexpression.

Eberlin LS, Gabay M, Fan AC, Gouw AM, Tibshirani RJ, Felsher DW, Zare RN.

Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10450-5. doi: 10.1073/pnas.1409778111. Epub 2014 Jul 3.

8.

MYC and the control of DNA replication.

Dominguez-Sola D, Gautier J.

Cold Spring Harb Perspect Med. 2014 Jun 2;4(6). pii: a014423. doi: 10.1101/cshperspect.a014423. Review.

PMID:
24890833
9.

MYC activation is a hallmark of cancer initiation and maintenance.

Gabay M, Li Y, Felsher DW.

Cold Spring Harb Perspect Med. 2014 Jun 2;4(6). pii: a014241. doi: 10.1101/cshperspect.a014241. Review.

PMID:
24890832
10.

ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.

Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.

Gastroenterology. 2014 Aug;147(2):430-442.e8. doi: 10.1053/j.gastro.2014.04.047. Epub 2014 May 15.

PMID:
24846398
11.

Inactivation of MYC reverses tumorigenesis.

Li Y, Casey SC, Felsher DW.

J Intern Med. 2014 Jul;276(1):52-60. doi: 10.1111/joim.12237. Review.

12.

Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.

Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi K, Gu Y, Fang G.

FEBS J. 2014 Feb;281(3):802-13. doi: 10.1111/febs.12625. Epub 2014 Jan 15.

PMID:
24397586
13.

Wogonin has multiple anti-cancer effects by regulating c-Myc/SKP2/Fbw7α and HDAC1/HDAC2 pathways and inducing apoptosis in human lung adenocarcinoma cell line A549.

Chen XM, Bai Y, Zhong YJ, Xie XL, Long HW, Yang YY, Wu SG, Jia Q, Wang XH.

PLoS One. 2013 Nov 12;8(11):e79201. doi: 10.1371/journal.pone.0079201. eCollection 2013.

14.

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma.

Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S, Long X, Jiang Q, Song Y, Cheng C, Wang H, Zhao M, Fu Q, Lyu X, Chen Y, Fan Y, Liu Y, Li X, Fang W.

Cell Death Dis. 2013 Oct 24;4:e872. doi: 10.1038/cddis.2013.376.

15.

MYC phosphorylation at novel regulatory regions suppresses transforming activity.

Wasylishen AR, Chan-Seng-Yue M, Bros C, Dingar D, Tu WB, Kalkat M, Chan PK, Mullen PJ, Huang L, Meyer N, Raught B, Boutros PC, Penn LZ.

Cancer Res. 2013 Nov 1;73(21):6504-15. doi: 10.1158/0008-5472.CAN-12-4063. Epub 2013 Sep 12.

16.

Generation of a tetracycline regulated mouse model of MYC-induced T-cell acute lymphoblastic leukemia.

Rakhra K, Felsher DW.

Methods Mol Biol. 2013;1012:221-35. doi: 10.1007/978-1-62703-429-6_15.

PMID:
24006068
17.

Investigating Myc-dependent translational regulation in normal and cancer cells.

Cunningham JT, Pourdehnad M, Stumpf CR, Ruggero D.

Methods Mol Biol. 2013;1012:201-12. doi: 10.1007/978-1-62703-429-6_13.

18.

Methods to quantify microRNAs in the Myc gene network for posttranscriptional gene repression.

Song R, Sponer N, He L.

Methods Mol Biol. 2013;1012:135-44. doi: 10.1007/978-1-62703-429-6_10.

19.

Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data.

Xiong L, Jiang W, Zhou R, Mao C, Guo Z.

Comput Biol Med. 2013 Sep;43(9):1252-60. doi: 10.1016/j.compbiomed.2013.06.002. Epub 2013 Jun 13.

PMID:
23930820
20.

MYC, metabolism, cell growth, and tumorigenesis.

Dang CV.

Cold Spring Harb Perspect Med. 2013 Aug 1;3(8). pii: a014217. doi: 10.1101/cshperspect.a014217.

PMID:
23906881
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk